| 000 | 02450 a2200709 4500 | ||
|---|---|---|---|
| 005 | 20250516033543.0 | ||
| 264 | 0 | _c20110628 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(11)70081-X _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMoreau, Philippe | |
| 245 | 0 | 0 |
_aSubcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _cMay 2011 |
||
| 300 |
_a431-40 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAsia |
| 650 | 0 | 4 |
_aBlood Cells _xdrug effects |
| 650 | 0 | 4 |
_aBoronic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aBortezomib |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Myeloma _xblood |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
| 650 | 0 | 4 |
_aProtease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrazines _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aSouth America |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPylypenko, Halyna | |
| 700 | 1 | _aGrosicki, Sebastian | |
| 700 | 1 | _aKaramanesht, Ievgenii | |
| 700 | 1 | _aLeleu, Xavier | |
| 700 | 1 | _aGrishunina, Maria | |
| 700 | 1 | _aRekhtman, Grigoriy | |
| 700 | 1 | _aMasliak, Zvenyslava | |
| 700 | 1 | _aRobak, Tadeusz | |
| 700 | 1 | _aShubina, Anna | |
| 700 | 1 | _aArnulf, Bertrand | |
| 700 | 1 | _aKropff, Martin | |
| 700 | 1 | _aCavet, James | |
| 700 | 1 | _aEsseltine, Dixie-Lee | |
| 700 | 1 | _aFeng, Huaibao | |
| 700 | 1 | _aGirgis, Suzette | |
| 700 | 1 | _avan de Velde, Helgi | |
| 700 | 1 | _aDeraedt, William | |
| 700 | 1 | _aHarousseau, Jean-Luc | |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 12 _gno. 5 _gp. 431-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(11)70081-X _zAvailable from publisher's website |
| 999 |
_c20773226 _d20773226 |
||